Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lansoprazole in non-erosive reflux disease (Japan, jRCT1080221028)
jRCT1080221028Phase 4
- Sponsor
- Takeda
- Start
- Feb 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of lansoprazole in gastroesophageal reflux disease (GERD), sponsored by Takeda.
02
Drugs
lansoprazole
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on jRCT1080221028.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080221028.